您当前的位置:
首页 >
文章列表页 >
The efficacy of tucatinib-based therapeutic approaches for HER2-positive breast cancer
The efficacy of tucatinib-based therapeutic approaches for HER2-positive breast cancer
The efficacy of tucatinib-based therapeutic approaches for HER2-positive breast cancer
- 解放军医学杂志(英文版) 2022年9卷第5期 页码:628-636
DOI: 10.1186/s40779-022-00401-3
移动端阅览
HTML全文
图( 1 ) 表( 2 )
参考文献
出版信息
数据统计
19
浏览量
16
下载量
0
CSCD
文章被引用时,请邮件提醒。
提交
工具集
- BibTeX下载
- Endnote下载
- RefMan 下载
- NoteExpress下载
- NoteFirst下载
相关文章
Crosstalk in the brain tumor microenvironment: mechanisms, therapeutic strategies, and clinical advances
Accelerating global efforts to prevent women’s cancers
Reprogramming neural-tumor crosstalk: emerging therapeutic dimensions and targeting strategies
Immunotherapy for tuberculosis: current strategies and future directions
Metal-based nanomedicines for cancer theranostics
相关作者
Gui-Long Tanzhu
Liu Chen
Jiao-Yang Ning
Gang Xiao
Su Wen
Ce Wang
Hao Wen
Ke-Qin Zhang
相关机构
Department of Oncology, Xiangya Hospital, Central South University
Department of Radiation Oncology, Hunan Cancer Hospital/Affiliated Hospital of Xiangya School of Medicine, Central South University
Xiangya Lung Cancer Center, Xiangya Hospital, Central South University
Department of Neuroscience, West Virginia University School of Medicine, Rockefeller Neuroscience Institute
Department of Pharmaceutical Sciences, West Virginia University School of Pharmacy

